Purple Biotech Ltd. (PPBT)
Purple Biotech Ltd. Statistics
Share Statistics
Purple Biotech Ltd. has 13.24K shares outstanding. The number of shares has increased by -90.43% in one year.
Shares Outstanding | 13.24K |
Shares Change (YoY) | -90.43% |
Shares Change (QoQ) | 2.53% |
Owned by Institutions (%) | 0% |
Shares Floating | 13.14K |
Failed to Deliver (FTD) Shares | 306 |
FTD / Avg. Volume | 1.2% |
Short Selling Information
The latest short interest is 19.52K, so 0.74% of the outstanding shares have been sold short.
Short Interest | 19.52K |
Short % of Shares Out | 0.74% |
Short % of Float | 0.76% |
Short Ratio (days to cover) | 0.43 |
Valuation Ratios
The PE ratio is -0.11 and the forward PE ratio is -2.1. Purple Biotech Ltd.'s PEG ratio is 0.
PE Ratio | -0.11 |
Forward PE | -2.1 |
PS Ratio | 0 |
Forward PS | 0 |
PB Ratio | 0.02 |
P/FCF Ratio | -0.06 |
PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Purple Biotech Ltd..
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.23, with a Debt / Equity ratio of 0.01.
Current Ratio | 2.23 |
Quick Ratio | 2.23 |
Debt / Equity | 0.01 |
Debt / EBITDA | -0.03 |
Debt / FCF | -0.01 |
Interest Coverage | -268.41 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $0 |
Profits Per Employee | $-804.44K |
Employee Count | 9 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -81.03% in the last 52 weeks. The beta is 0.29, so Purple Biotech Ltd.'s price volatility has been higher than the market average.
Beta | 0.29 |
52-Week Price Change | -81.03% |
50-Day Moving Average | 3 |
200-Day Moving Average | 5.13 |
Relative Strength Index (RSI) | 42.79 |
Average Volume (20 Days) | 25.54K |
Income Statement
Revenue | n/a |
Gross Profit | 0 |
Operating Income | -11.01M |
Net Income | -7.24M |
EBITDA | -7.05M |
EBIT | -7.24M |
Earnings Per Share (EPS) | -0.21 |
Balance Sheet
The company has 7.4M in cash and 183K in debt, giving a net cash position of 7.22M.
Cash & Cash Equivalents | 7.4M |
Total Debt | 183K |
Net Cash | 7.22M |
Retained Earnings | -144.69M |
Total Assets | 37.04M |
Working Capital | 4.92M |
Cash Flow
In the last 12 months, operating cash flow was -14.37M and capital expenditures 0, giving a free cash flow of -14.37M.
Operating Cash Flow | -14.37M |
Capital Expenditures | 0 |
Free Cash Flow | -14.37M |
FCF Per Share | -0.41 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
PPBT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for PPBT is $33, which is 1131.3% higher than the current price. The consensus rating is "Buy".
Price Target | $33 |
Price Target Difference | 1131.3% |
Analyst Consensus | Buy |
Analyst Count | 1 |
Stock Splits
The last stock split was on Sep 17, 2024. It was a backward split with a ratio of 1:20.
Last Split Date | Sep 17, 2024 |
Split Type | backward |
Split Ratio | 1:20 |
Scores
Altman Z-Score | -5.95 |
Piotroski F-Score | 1 |